CA2343572C - Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein - Google Patents

Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein Download PDF

Info

Publication number
CA2343572C
CA2343572C CA002343572A CA2343572A CA2343572C CA 2343572 C CA2343572 C CA 2343572C CA 002343572 A CA002343572 A CA 002343572A CA 2343572 A CA2343572 A CA 2343572A CA 2343572 C CA2343572 C CA 2343572C
Authority
CA
Canada
Prior art keywords
breast cancer
vitamin
gene
vdr
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002343572A
Other languages
English (en)
Other versions
CA2343572A1 (fr
Inventor
Francois Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Laval filed Critical Universite Laval
Publication of CA2343572A1 publication Critical patent/CA2343572A1/fr
Application granted granted Critical
Publication of CA2343572C publication Critical patent/CA2343572C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une méthode de détermination de la prédisposition d'un individu au cancer du sein, du développement du cancer du sein et/ou de la réactivité au traitement du cancer du sein. Ledit procédé consiste à déterminer le génotype du récepteur de la vitamine D de l'individu, la prédisposition de l'individu au cancer du sein, le développement du cancer du sein et/ou la réactivité au traitement du cancer du sein.
CA002343572A 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein Expired - Fee Related CA2343572C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10044898P 1998-09-15 1998-09-15
US60/100,448 1998-09-15
PCT/CA1999/000853 WO2000015835A2 (fr) 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein

Publications (2)

Publication Number Publication Date
CA2343572A1 CA2343572A1 (fr) 2000-03-23
CA2343572C true CA2343572C (fr) 2008-01-22

Family

ID=22279822

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343572A Expired - Fee Related CA2343572C (fr) 1998-09-15 1999-09-15 Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein

Country Status (4)

Country Link
EP (1) EP1114180A2 (fr)
AU (1) AU5723299A (fr)
CA (1) CA2343572C (fr)
WO (1) WO2000015835A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270094B1 (en) 1999-03-26 2001-08-07 William F. Campbell Multi-purpose wire dispensing cart

Also Published As

Publication number Publication date
WO2000015835A3 (fr) 2000-07-13
CA2343572A1 (fr) 2000-03-23
AU5723299A (en) 2000-04-03
WO2000015835A2 (fr) 2000-03-23
EP1114180A2 (fr) 2001-07-11

Similar Documents

Publication Publication Date Title
EP0821733B1 (fr) Marqueurs genetiques pour le cancer du sein et des ovaires
US9909189B2 (en) Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
EP1690948A2 (fr) Detection spécifique de la méthylation
JP2002505888A (ja) 唾液分析による新生物の検出
AU720500B2 (en) Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
US6444427B1 (en) Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof
CA2343572C (fr) Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein
US20060040263A1 (en) Marker at the androgen receptor gene for determining breast cancer susceptibility
EP1394268A1 (fr) HNF1alpha en tant que suppresseur de tumeur et utilisation thérapeutiques et diagnostiques de celle-ci
CA2343049A1 (fr) Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose
WO2001073116A2 (fr) Methode permettant de determiner la probabilite d'etre atteint d'osteoporose et/ou une faible densite osseuse, et reactifs destines a cette methode
JP2001518311A (ja) 遺伝子座の階層化による疾病の関連づけ
WO2002006522A2 (fr) Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible
AU5645200A (en) Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
WO2005033339A1 (fr) Polymorphisme du gene du recepteur de type toll-3 humain utilise en tant que marqueur du facteur herite d'une maladie allergique et utilisation de ce marqueur
JP2007503806A (ja) ヒト肥満感受性遺伝子およびその使用

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160915